Skip to main content
XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
1.300
-0.020 (-1.52%)
At close: Mar 9, 2026, 4:00 PM EDT
1.230
-0.070 (-5.38%)
After-hours: Mar 9, 2026, 7:23 PM EDT

XWELL Revenue

XWELL had revenue of $7.35M in the quarter ending September 30, 2025, a decrease of -12.79%. This brings the company's revenue in the last twelve months to $29.52M, down -12.74% year-over-year. In the year 2024, XWELL had annual revenue of $33.90M with 12.58% growth.

Revenue (ttm)
$29.52M
Revenue Growth
-12.74%
P/S Ratio
0.24
Revenue / Employee
$94,625
Employees
312
Market Cap
7.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202433.90M3.79M12.58%
Dec 31, 202330.11M-25.83M-46.18%
Dec 31, 202255.94M-17.79M-24.13%
Dec 31, 202173.73M65.34M779.30%
Dec 31, 20208.39M-38.92M-82.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
MDxHealth 107.88M
FONAR 106.03M
Exagen 63.60M
Precipio 22.80M
bioAffinity Technologies 6.78M
iSpecimen 3.35M
Mainz Biomed 659.94K
Revenue Rankings

XWEL News

More News